Home/Filings/4/0001437749-24-021123
4//SEC Filing

Barrett Burke Thomas 4

Accession 0001437749-24-021123

CIK 0001625101other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 7:31 PM ET

Size

7.6 KB

Accession

0001437749-24-021123

Insider Transaction Report

Form 4
Period: 2024-05-12
Barrett Burke Thomas
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (right to buy)

    2024-05-12+700,000700,000 total
    Exercise: $7.45Exp: 2034-05-12Common Stock (700,000 underlying)
  • Award

    Stock Option (right to buy)

    2024-05-12+700,000700,000 total
    Exercise: $7.45Exp: 2034-05-12Common Stock (700,000 underlying)
Footnotes (2)
  • [F1]The shares will vest in four equal annual installments on each of the first four annual anniversaries of the grant date, subject to the Reporting Person's continued service through each vesting date.
  • [F2]The shares subject to this option are subject to five tranches of performance-based vesting criteria tied to Issuer's market capitalization, with no vesting until the Issuer's market capitalization exceeds $1 billion, in all cases, subject to the Reporting Person's continued service through each vesting milestone.

Issuer

Pulse Biosciences, Inc.

CIK 0001625101

Entity typeother

Related Parties

1
  • filerCIK 0002023875

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 7:31 PM ET
Size
7.6 KB